Picture of Biohaven logo

BHVN Biohaven Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapMomentum Trap

Annual cashflow statement for Biohaven, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-119-214-570-408
Depreciation
Non-Cash Items33.764.930044.9
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital8.981.66-28.624.6
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-76-146-298-332
Capital Expenditures-2.7-0.938-6.07-3.05
Purchase of Fixed Assets
Other Investing Cash Flow Items01.88-299133
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-2.70.944-305130
Financing Cash Flow Items152138484-31.3
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities152138768212
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash73.6-6.451669.52